P00533 (EGFR_HUMAN) Homo sapiens (Human)

Epidermal growth factor receptor UniProtKBInterProSTRINGInteractive Modelling

1210 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4)

Available Structures

241 Experimental Structures

DescriptionOligo-stateLigandsStructureRange
The Extracellular and Transmembrane Domain Interfaces in Epidermal Growth Factor Receptor Signaling Heteromer
P01133;
12×NAG;2PE;25-638
Assess
The complex structure of extracellular domain of EGFR and GC1118A Heteromer
NAG;NAG;NAG;25-637
Assess
Structure of the extracellular domain of the epidermal growth factor receptor in complex with the F… Heteromer
NAG;NAG;NAG;26-638
Assess
Crystal structure of the extracellular domain of the epidermal growth factor receptor in complex wi… Heteromer
NAG;NAG;NAG;NAG;26-638
Assess
Structure of the extracellular domain of human epidermal growth factor (EGF) receptor in an inactiv… Heteromer
P01133;
NAG;NAG;NAG;27-638
Assess
The complex structure of extracellular domain of EGFR with Repebody (rAC1). Heteromer
E0ACT6; Q4G1L3;
NAG;NAG;26-637
Assess
Crystal structure of the complex of 059-152-Fv and EGFR-ECD Heteromer
NAG;NAG; 20×ZN;28-638
Assess
Nanobody/VHH domain 9G8 in complex with the extracellular region of EGFR Heteromer
NAG;NAG;28-636
Assess
Structure of Cetuximab Fab mutant in complex with EGFR extracellular domain Heteromer
NAG;NAG;NAG;28-636
Assess
Nanobody/VHH domain EgA1 in complex with the extracellular region of EGFR Heteromer
NAG;NAG;28-628
Assess
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domain… Heteromer
P01133;
NAG;NAG;26-536
Assess
Crystal Structure of Human Epidermal Growth Factor Receptor (residues 1-501) in complex with TGF-al… Heteromer
P01135;
NAG;NAG;NAG;NAG;PT; 11×CD;CL;NAG;25-525
Assess
Crystal structure of the epidermal growth factor receptor extracellular region in complex with epir… Heteromer
O14944;
NAG;NAG;NAG;26-525
Assess
Crystal structure of the epidermal growth factor receptor extracellular region with A265V mutation … Heteromer
O14944;
NAG;NAG;26-525
Assess
Crystal structure of the epidermal growth factor receptor extracellular region with R84K mutation i… Heteromer
O14944;
NAG;NAG;NAG;27-525
Assess
Crystal structure of the epidermal growth factor receptor extracellular region in complex with epig… Heteromer
Q6UW88;
NAG;NAG;27-525
Assess
Crystal structure of the epidermal growth factor receptor extracellular region with R84K mutation i… Heteromer
O14944;
NAG;NAG;MAN;BMA;27-525
Assess
Crystal structure of the extracellular region of the epidermal growth factor receptor in complex wi… Heteromer
Q6GMX6;
NAG;NAG;NAG;263-637
Assess
EGFR L858R MUTANT IN COMPLEX WITH A SHC PEPTIDE SUBSTRATE Heteromer
P29353;
696-1018
Assess
Crystal structures of EGFR in complex with Mig6 Heteromer
Q9UJM3;
696-1018
Assess
Crystal structures of EGFR in complex with Mig6 Heteromer
Q9UJM3;
696-1018
Assess
Crystal structure of L858R + T790M EGFR kinase domain in complex with MIG6 peptide Heteromer
Q9UJM3;
703-1019
Assess
Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide Heteromer
Q9UJM3;
SO4;703-1018
Assess
Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide Heteromer
Q9UJM3;
702-1002
Assess
Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-E… Heteromer
P21860;
ANP;MG;ADP;688-984
Assess
Crystal structure of an EGFR/HER3 kinase domain heterodimer Heteromer
P21860;
ANP;MG;ADP;688-984
Assess
Crystal structure of an EGFR/HER3 kinase domain heterodimer containing the cancer-associated HER3-Q… Heteromer
P21860;
ANP;MG;ADP;688-984
Assess
Crystal structure of the complex between the EGFR kinase domain and a Mig6 peptide Heteromer
Q9UJM3;
699-983
Assess
crystal structure of EGFR kinase domain in complex with Mitogen-inducible gene 6 protein Heteromer
Q9UJM3;
703-985
Assess
Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 6.0 Heteromer
NAG;MES;NAG;IOD;335-535
Assess
anti-EGFR/HER3 Fab DL11 in complex with domain III of EGFR extracellular region Heteromer
NAG;NAG;GOL;334-527
Assess
Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 3.5 Heteromer
NAG;NAG;335-527
Assess
Crystal structure of isolated domain III of the extracellular region of the epidermal growth factor… Heteromer
Q6GMX6;
NAG;NAG;NAG;SO4;335-526
Assess
Crystal Structure of panitumumab in complex with epidermal growth factor receptor domain 3 mutant S… Heteromer
SO4;GOL;EDO;1PE;335-525
Assess
Crystal Structure of panitumumab in complex with epidermal growth factor receptor domain 3. Heteromer
SO4;GOL;1PE;336-525
Assess
Crystal structure of the Fab fragment of necitumumab (Fab11F8) in complex with domain III from a ce… Heteromer
NAG;NAG;NAG;335-524
Assess
Crystal structure the Fab fragment of matuzumab (Fab72000) in complex with domain III of the extrac… Heteromer
NAG;BMA;336-524
Assess
Heterodimeric association of Transmembrane domains of ErbB1 and ErbB2 receptors Enabling Kinase Act… Heteromer
P04626;
634-677
Assess
Antibodies Specifically Targeting a Locally Misfolded Region of Tumor Associated EGFR Heteromer
311-326
Assess
Antibodies Specifically Targeting a Locally Misfolded Region of Tumor Associated EGFR Heteromer
ACT;GOL;FMT;311-326
Assess
Crystal structure of c-Cbl TKB domain in complex with double phosphorylated EGFR peptide Heteromer
P22681;
1064-1074
Assess
Crystal structure of c-Cbl-TKB domain complexed with its binding motif in EGF receptor Heteromer
P22681;
1064-1074
Assess
Crystal structure of Cbl-b TKB domain in complex with EGFR pY1069 peptide Heteromer
Q13191;
NA;CL;SO4;EDO;1066-1075
Assess
Crystal structure of Cbl-c (Cbl-3) TKB domain in complex with EGFR pY1069 peptide Heteromer
Q9ULV8;
NA;NI;1066-1075
Assess
Crystal structure of the tyrosine kinase binding domain of Cbl-c in complex with phospho-EGFR pepti… Heteromer
Q9ULV8;
CA;1067-1074
Assess
Crystal structure of the tyrosine kinase binding domain of Cbl-c (PL mutant) in complex with phosph… Heteromer
Q9ULV8;
CA;1067-1074
Assess
Crystal structure of EGFR 696-1022 T790M in complex with LXX-6-26homo-4-mer816;EDO;700-1016
Assess
Crystal structure of the EGF receptor juxtamembrane and kinase domainshomo-2-mer676-1018
Assess
Crystal structure of mutated EGFR kinase domain (G719S)homo-2-mer696-1019
Assess
Crystal structure of EGFR double mutant (T790M/L858R) in complex with compound 6.homo-2-mer35Z;696-1019
Assess
Crystal Structure of the active EGFR kinase domain in complex with an ATP analog-peptide conjugatehomo-2-merCL;112;696-1019
Assess
Crystal structure of EGFR kinase domain in complex with compound 3ghomo-2-merKJR;696-1019
Assess
Crystal structure of EGFR kinase domain in complex with compound 2ahomo-2-merKJQ;696-1019
Assess
Crystal structure of EGFR kinase domain in complex with compound 4chomo-2-merKJV;696-1019
Assess
Crystal structure of EGFR kinase domain in complex with compound 4bhomo-2-merKJ8;696-1019
Assess
Crystal structure of EGFR 696-1022 T790M/C797S in complex with Go6976homo-2-mer85X;CL;697-1020
Assess
Crystal structure of the wild-type EGFR kinase domain in complex with AMPPNP.homo-2-merANP;696-1018
Assess
Crystal Structure of the active EGFR kinase domainhomo-2-mer696-1018
Assess
Crystal structure of mutated EGFR kinase domain (L858R) in complex with AMPPNPhomo-2-merANP;696-1018
Assess
EGFR in complex with a dihydrodibenzodiazepinone allosteric inhibitor.homo-2-merANP;O57;MG;AMP;EDO;698-1019
Assess
Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in complex with AMPPNP.homo-2-merANP;697-1018
Assess
Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in complex with gefitinibhomo-2-merIRE;MES;697-1018
Assess
Crystal structure of the mutated EGFR kinase domain (G719S/T790M) in the apo formhomo-2-merMES;697-1018
Assess
EGFR L858R/T790M in complex with PD168393homo-2-merYUN;697-1017
Assess
Crystal structure of EGFR 696-1022 T790M/V948R in complex with SKLB(6)homo-2-mer7XU;697-1014
Assess
Crystal structure of EGFR 696-1022 T790M/V948R, crystal form IIhomo-2-merANP;MG;699-1015
Assess
EGFR kinase domain in complex with mutant selective allosteric inhibitorhomo-2-merMG;ANP;57N;698-1014
Assess
Crystal structure of EGFR(T790M/V948R) in complex with LN3753homo-2-merTOV;CL;699-1014
Assess
Crystal Structure of the inactive EGFR kinase domain in complex with AMP-PNPhomo-2-merMG; 11×IOD;ANP;701-1016
Assess
Crystal structure of EGFR 696-1022 T790M/V948R in complex with SKLB(3)homo-2-merCL;EDO;7XO;ANP;MG;700-1014
Assess
EGFR(T790M/V948R) in complex with LN2057homo-2-merCL;QQJ;700-1014
Assess
EGFR(T790M/V948R) in complex with LN2899homo-2-merCL;EDO;QP1;701-1014
Assess
EGFR(T790M/V948R) in complex with LN2380homo-2-merCL;QQM;701-1014
Assess
EGFR(T790M/V948R) in complex with LN2725homo-2-merQP4;CL;701-1014
Assess
A crystal structure of EGFR(T790M/V948R) in complex with LN3754homo-2-merANP;MG;701-1014
Assess
Crystal structure of EGFR with mutant-selective dihydrodibenzodiazepinone allosteric inhibitorhomo-2-merANP;NQ1;MG;701-1013
Assess
EGFR with an allosteric inhibitorhomo-2-merMG;ANP;JBJ;699-1007
Assess
Crystal structure of the inactive EGFR kinase domain in complex with AMP-PNPhomo-2-merANP;MG;699-1007
Assess
EGFR kinase (T790M/V948R) in complex with allosteric inhibitor JBJ-09-063homo-2-merMG;ANP;VNS;700-1007
Assess
EGFR kinase (T790M/V948R) in complex with osimertinib and JBJ-04-125-02homo-2-merANP;MG;JBJ;700-1007
Assess
EGFR kinase (T790M/V948R) in complex with osimertinib and EAI045homo-2-merANP;MG;9LL;700-1007
Assess
EGFR(T790M/V948R) in complex with LN2084homo-2-merQP7;CL;701-1008
Assess
EGFR kinase (T790M/V948R) in complex with AZ5104homo-2-merVO7;700-1007
Assess
EGFR kinase (T790M/V948R) in complex with osimertinib and JBJ-09-063homo-2-merYY3;VNS;700-1007
Assess
EGFR L858R/V948R in complex with osimertinib and allosteric inhibitor JBJ-09-063homo-2-merVNS;YY3;701-1008
Assess
EGFR kinase (T790M/V948R) in complex with PF-06747775homo-2-mer8BS;700-1007
Assess
EGFR kinase (T790M/V948R) in complex with PF-06747775 and JBJ-04-125-02homo-2-merANP;MG;JBJ;8BS;700-1007
Assess
EGFR kinase (L858R/V948R) in complex with allosteric inhibitor JBJ-09-063homo-2-merMG;ANP;VNS;700-1007
Assess
Crystal structure of EGFR in complex with EAI045homo-2-merMG;ANP;9LL;701-1007
Assess
EGFR transmembrane - juxtamembrane (TM-JM) segment in bicelles: MD guided NMR refined structure.homo-2-mer642-697
Assess
N-terminal motif dimerization of EGFR transmembrane domain in bicellar environmenthomo-2-mer634-677
Assess
Homodimeric transmembrane domain of the human receptor tyrosine kinase ErbB1 (EGFR, HER1) in micell…homo-2-mer634-677
Assess
Crystal structure of EGFR 696-1022 T790M in complex with QL-X138monomer3LH;694-1021
Assess
1.85 angstrom structure of EGFR kinase domain with gefitinibmonomerIRE;NA;MES;696-1020
Assess
EGFR-T790M in complex with pyrazolopyrimidine inhibitor 1amonomer6HJ;696-1020
Assess
Crystal structure of EGFR 696-1022 L858R in complex with AZD9291monomerYY3;696-1020
Assess
Tyrosine Kinase Domain from Epidermal Growth Factor Receptormonomer696-1020
Assess
EGFR-K IN COMPLEX WITH N-[3-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-4-methoxy-phenyl] Pro…monomer1WY;NA;696-1020
Assess
Crystal Structure of EGFR 696-1022 T790M Mutant Covalently Binding to WZ4002monomer0UN;696-1020
Assess
Crystal structure of EGFR kinase domain in complex with an irreversible inhibitor 34-jabmonomerDJK;696-1020
Assess
Crystal structure of EGFR kinase domain in complex with an irreversible inhibitor 13-jabmonomerCL;696-1020
Assess
Crystal structure of EGFR 696-1022 T790M in complex with WZ4003monomer0UN;696-1020
Assess
1.9 angstrom structure of EGFR kinase domainmonomerNA;MES;696-1019
Assess
EGFR kinase domain mutant "TMLR" with compound 41amonomerSO4;4ZQ;696-1019
Assess
Wild type EGFR in complex with LN2057monomerQQJ;696-1019
Assess
EGFR kinase domain mutant "TMLR" with compound 23monomerSO4;4YX;696-1019
Assess
EGFR kinase domain mutant "TMLR" with 3-carboxamide azaindole compound 13monomerSO4;60D;696-1019
Assess
Crystal structure of EGFR kinase domain L858R mutation in complex with AMP-PNPmonomerANP;696-1019
Assess
Crystal structure of EGFR kinase domain G719S mutation in complex with AMP-PNPmonomerMG;ANP;696-1019
Assess
Crystal structure of the EGFR kinase domain in complex with 4-(4-{[2-{[(3S)-1-acetylpyrrolidin-3-yl…monomer8BM;695-1018
Assess
Discovery of a Highly Potent and Broadly Effective EGFR and HER2 Exon 20 Insertion Mutant InhibitormonomerFZP;696-1019
Assess
Epidermal Growth Factor Receptor tyrosine kinase domain with 4-anilinoquinazoline inhibitor erlotin…monomerAQ4;696-1019
Assess
EGFR kinase domain mutant "TMLR" with 3-azetidinyl azaindazole compound 21monomerSO4;60E;696-1019
Assess
Studies Towards a Reversible EGFR C797S Triple Mutant Inhibitor Seriesmonomer6GY;695-1018
Assess
EGFR kinase domain with compound 41amonomer4ZQ;697-1020
Assess
EGFR-KINASE IN COMPLEX WITH COMPOUND 5monomerL1K;DMS;696-1019
Assess
Crystal structure of EGFR 696-1022 T790M in complex with XTF-262monomerF62;696-1019
Assess
EGFR kinase domain mutant "TMLR" with compound 27monomerSO4;4ZB;696-1019
Assess
Crystal structure of the wild-type EGFR kinase domain in complex with dacomitinib (soaked)monomer1C9;695-1018
Assess
Wild type EGFR in complex with LN2380monomerQQM;696-1019
Assess
Crystal structure of EGFR kinase domain L858R mutation in complex with IressamonomerCL;IRE;697-1020
Assess
Crystal structure of EGFR kinase domain L858R mutation in complex with AFN941monomerITQ;696-1019
Assess
EGFR kinase domain mutant "TMLR" with pyridone compound 13: 4-[(2-methoxyphenyl)amino]-~{N}-[4-(4-m…monomerSO4;5Q4;696-1019
Assess
Crystal structure of EGFR kinase domain in complex with compound 78monomerCKO;696-1019
Assess
Crystal structure of EGFR 696-1022 L858R in complex with SKLB(3)monomer7XO;CL;697-1020
Assess
Crystal structure of EGFR 696-1022 L858R in complex with SKLB(5)monomer7XR;CL;697-1020
Assess
Crystal structure of EGFR 696-1022 L858R in complex with SKLB(6)monomer7XU;CL;697-1020
Assess
Crystal structure of EGFR 696-1022 T790M in complex with Go6976monomer85X;696-1019
Assess
Crystal structure of EGFR 696-1022 T790M in complex with JTS-1-39monomer81C;EDO;CL;697-1020
Assess
Crystal structure of EGFR kinase domain in complex with AEE788monomerAEE;697-1020
Assess
Crystal structure of EGFR kinase domain G719S mutation in complex with IressamonomerIRE;696-1019
Assess
Crystal Structure of EGFR T790M mutant in complex with naquotinibmonomer8RC;697-1020
Assess
Wild type EGFR in complex with LN2899monomerQP1;696-1019
Assess
Crystal Structure of EGFR(L858R/T790M/C797S) in complex with OsimertinibmonomerYY3;696-1018
Assess
EGFR kinase domain mutant "TMLR" with compound 41bmonomerSO4;4ZR;696-1018
Assess
Crystal Structure of EGFR(L858R/T790M/C797S) in complex with CH7233163monomerEUX;696-1018
Assess
Crystal structure of EGFR 696-1022 T790M in complex with CO-1686monomer8JC;696-1018
Assess
EGFR kinase domain mutant "TMLR" with compound 30monomerSO4;4ZH;697-1019
Assess
EGFR L858R in complex with PD168393monomerDJK;CL;697-1019
Assess
Crystal structure of EGFR 696-1022 T790M in complex with AZD9291 prepared by soakingmonomerYY3;696-1018
Assess
EGFR kinase domain mutant "TMLR" with compound 29monomer4ZG;697-1019
Assess
EGFR kinase domain mutant "TMLR" with a imidazopyridinyl-aminopyrimidine inhibitormonomerSO4;63N;697-1019
Assess
EGFR kinase domain mutant "TMLR" with azabenzimidazole compound 7monomerSO4;60B;696-1018
Assess
EGFR kinase domain mutant "TMLR" with pyridone compound 2: 4-[2-(4-chlorophenyl)ethylamino]-~{N}-[4…monomer5Q2;697-1019
Assess
Crystal structure of EGFR 696-1022 L858R in complex with CO-1686monomer8JC;696-1018
Assess
Crystal structure of EGFR kinase domain L858R mutation in complex with AEE788monomerAEE;697-1019
Assess
EGFR kinase domain mutant "TMLR" with pyridone compound 19: 4-[(2-azanylpyrimidin-4-yl)amino]-~{N}-…monomerSO4;5Q3;697-1019
Assess
The structure of co-crystals of 8r-B-EGFR WT complexmonomerC6O;696-1018
Assess
EGFR kinase domain with pyridone compound 13: 4-[(2-methoxyphenyl)amino]-~{N}-[4-(4-methylpiperazin…monomer5Q4;696-1018
Assess
EGFR-T790M in complex with pyrazolopyrimidine inhibitor 1bmonomer6HL;697-1019
Assess
EGFR L858R MUTANT IN COMPLEX WITH AN OPTIMAL PEPTIDE SUBSTRATEmonomer696-1018
Assess
EGFR kinase domain mutant "TMLR" with a pyrazolopyrimidine inhibitormonomer63M;696-1018
Assess
Crystal structure of EGFR kinase domain in complex with AFN941monomerITQ;696-1018
Assess
EGFR kinase domain mutant "TMLR" with compound 17monomer4YW;697-1019
Assess
The structure of co-crystals of 8r-B-EGFR T790M/C797S complexmonomerC6O;696-1018
Assess
Crystal structure of EGFR kinase domain in complex with AMP-PNPmonomerANP;697-1019
Assess
EGFR kinase (T790M/L858R) with inhibitor compound 5monomer3QY;697-1019
Assess
Native-SAD phasing for human EGFR kinase domain.monomer697-1019
Assess
EGFR-KINASE IN COMPLEX WITH COMPOUND 1monomerL1H;697-1019
Assess
Crystal structure of EGFR kinase domain in complex with IressamonomerIRE;697-1019
Assess
EGFR T790M/C797S in complex with compound 6imonomer9JO;696-1017
Assess
EGFR kinase (T790M/L858R) with inhibitor compound 8monomerSO4;3QS;697-1018
Assess
EGFR kinase domain mutant "TMLR" with compound 33monomerSO4;4ZJ;697-1018
Assess
EGFR kinase (T790M/L858R) with inhibitor compound 1monomerSO4;3R1;697-1018
Assess
EGFR kinase (T790M/L858R) with inhibitor compound 27: ~{N}-(1~{H}-indazol-3-yl)-7,7-dimethyl-2-(2-m…monomer5N4;697-1018
Assess
Crystal Structure of EGFR-T790M/C797S in Complex with Covalent Pyrrolopyrimidine 19hmonomerMES;L0N;697-1018
Assess
Studies Towards a Reversible EGFR C797S Triple Mutant Inhibitor SeriesmonomerR85;697-1018
Assess
EGFR-KINASE IN COMPLEX WITH COMPOUND 6monomerL3Z;DMS;696-1017
Assess
Crystal structure of EGFR kinase domain G719S mutation in complex with AFN941monomerITQ;697-1018
Assess
EGFR kinase domain mutant "TMLR" with compound 24monomer4Z8;697-1018
Assess
EGFR kinase (T790M/L858R) with inhibitor compound 4monomerSO4;3R0;697-1018
Assess
EGFR kinase domain T790M mutant in complex with a covalent aminobenzimidazole inhibitor.monomer5X4;697-1018
Assess
Crystal structure of EGFR kinase domain G719S mutation in complex with AEE788monomerAEE;697-1018
Assess
EGFR kinase (T790M/L858R) with inhibitor compound 6monomer3QW;697-1018
Assess
EGFR kinase (T790M/L858R) with inhibitor compound 15: ~{N}-(7-chloranyl-1~{H}-indazol-3-yl)-7,7-dim…monomer5N3;697-1018
Assess
EGFR kinase (T790M/L858R) apomonomer697-1018
Assess
EGFR kinase domain mutant "TMLR" with compound 1monomer4YV;697-1018
Assess
Crystal structure of EGFR 696-1022 L858R in complex with FIIN-3monomerFI3;697-1018
Assess
EGFR Kinase domain T790M/L858R mutant with compound 2monomerW2P;698-1018
Assess
Crystal structure of EGFR 696-1022 T790M/C797S in complex with D3003monomer9JO;CL;697-1017
Assess
EGFR kinase domain in complex with a covalent aminobenzimidazole inhibitor.monomer5X4;697-1017
Assess
Crystal Structure of EGFR-T790M/C797S in Complex with Covalent Pyrrolopyrimidine 19gmonomerL0Q;MES;697-1017
Assess
Crystal structure of EGFR kinase in complex with BIBW2992monomer0WN;0WM;696-1016
Assess
Crystal structure of EGFR kinase domain T790M mutation in complex with AEE788monomerAEE;696-1016
Assess
Crystal structure of EGFR kinase domain T790M mutationmonomer696-1016
Assess
Crystal structure of EGFR kinase T790M in complex with BIBW2992monomer0WN;696-1016
Assess
EGFR KINASE DOMAIN IN COMPLEX WITH A COVALENT AMINOBENZIMIDAZOLEmonomer5XH;697-1017
Assess
EGFR Kinase domain T790M/L858R mutant with compound 4monomerW2R;EDO;698-1017
Assess
EGFR kinase domain T790M/L858R mutant with HKI-272monomerHKI;MES;698-1017
Assess
EGFR Kinase domain T790M/L858R Mutant with TAK-285monomer03P;698-1017
Assess
AZD9291 complex with wild type EGFRmonomerYY3;698-1017
Assess
EGFR kinase domain mutant (T790M/L858R) with covalent ligand NS-062monomer8LU;698-1017
Assess
EGFR kinase domain with compound4monomerW2R;SO4;701-1019
Assess
EGFR kinase domain complexed with compound 19bmonomerW19;SO4;701-1018
Assess
Crystal structure of EGFR 696-1022 T790M in complex with Ibrutinibmonomer1E8;700-1017
Assess
EGFR Kinase domain complexed with tak-285monomerSO4;03P;701-1017
Assess
EGFR kinase domain complexed with compound 20amonomerW32;SO4;701-1017
Assess
EGFR kinase domain complexed with a quinazoline inhibitor- GW572016monomerPO4;FMM;702-1018
Assess
Crystal structure of the EGFR kinase domain mutant V924RmonomerANP;MG;700-1015
Assess
Crystal structure of the EGFR kinase domain mutant I682QmonomerANP;MG;699-1014
Assess
Crystal structure of EGFR 696-1022 T790M/V948R in complex with SKLB(5)monomerEDO;7XR;700-1015
Assess
Structure of the monomeric (V948R)gefitinib/erlotinib resistant double mutant (L858R+T790M) EGFR ki…monomerIRE;SO4;700-1014
Assess
Structure of T790M EGFR kinase domain co-crystallized with dacomitinibmonomer1C9;700-1014
Assess
Structure of EGFR in complex with hydrazone, a potent dual inhibitormonomerPO4;HYZ;702-1016
Assess
X-ray structure of EGFR in complex with oxime inhibitormonomerPO4;POX;702-1015
Assess
EGFR(T790M/V948R) in complex with LN3844monomerUEJ;702-1014
Assess
EGFR(T790M/V948R) in complex with AZD9291 and DDC4002monomerQ6K;NQ1;700-1007
Assess
EGFR D770_N771insNPG in complex with PD168393monomerYUN;696-999
Assess
EGFR (L858R, T790M, V948R) in complex with N-{3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-7H-py…monomer633;SO4;GOL;700-1001
Assess
Crystal structure of EGFR tyrosine kinase domain with novel inhibitor of active state of HER2monomerSO4;6JS;699-999
Assess
EGFR (L858R, T790M, V948R) in complex with N-[3-({2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-pyrrolo[2,…monomer634;SO4;GOL;700-999
Assess
Crystal structure of EGFR kinase domain in complex with a sulfonyl fluoride probe XO44monomerO44;SO4;GOL;702-990
Assess
Crystal structure of EGFR 696-988 T790M in complex with LXX-6-34monomer80U; 11×NO3; 19×EDO;CL;697-985
Assess
Crystal structure of EGFR 696-1022 T790M in complex with AZD9291 prepared by co-crystallizationmonomerYY3;CL;701-989
Assess
Crystal structure of EGFR 696-1022 WT in complex with AZD9291 prepared by cocrystallizationmonomerYY3;CL;697-984
Assess
Crystal structure of the monomeric (V948R) form of the gefitinib/erlotinib resistant EGFR kinase do…monomer701-987
Assess
Crystal structure of monomeric (V948R) primary oncogenic mutant L858R EGFR kinase domainmonomer701-987
Assess
Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 21amonomerN78;EDO;SO4;700-985
Assess
Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 18bmonomerN7Q;EDO;SO4;700-985
Assess
Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 21bmonomerN82;EDO;SO4;699-984
Assess
Crystal Structure of EGFR-T790M/V948R in Complex with Spebrutinib and EAI001monomer57N;7G9;SO4;CL;700-984
Assess
Crystal structure of EGFR kinase domain T790M mutation in compex with HKI-272monomerHKI;700-984
Assess
Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhibi…monomer8AM;SO4;GOL;EDO;702-985
Assess
Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhibi…monomer8BP;SO4;GOL;702-985
Assess
Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with a covalent inhibi…monomer8BS;SO4;GOL;EDO;702-985
Assess
Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 18cmonomerN7Z;SO4;699-982
Assess
Crystal Structure of EGFR-T790M/V948R in Complex with Mavelertinib and EAI001monomer8BS;SO4;701-984
Assess
EGFR (L858R, T790M, V948R) in complex with 1-[(3R,4R)-3-[({2-[(1-methyl-1H-pyrazol-4-yl)amino]-7H-p…monomer63A;SO4;GOL;702-985
Assess
Crystal structure of EGFR 675-1022 T790M/C797S/V948R in complex with EAI045monomer9LL;702-985
Assess
Crystal structure of the EGFR kinase domain (L858R, T790M, V948R) in complex with 4-(4-{[2-{[(3S)-1…monomer8BM;SO4;GOL;703-985
Assess
EGFR (L858R, T790M, V948R) in complex with 1-{(3R,4R)-3-[5-Chloro-2-(1-methyl-1H-pyrazol-4-ylamino)…monomer630;SO4;702-984
Assess
Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 14dmonomerN7K;SO4;700-982
Assess
Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 18dmonomerN7W;SO4;MG;CL;700-982
Assess
Crystal Structure of EGFR-T790M/V948R in Complex with Osimertinib and EAI045monomerQ6K;9LL;SO4;700-982
Assess
Crystal structure of EGFR kinase domain (L858R, T790M, V948R) in complex with the covalent inhibito…monomer8OV;702-984
Assess
Structure of EGFR_D770_N771insNPG/V948R in complex with covalent inhibitor Osimertinib.monomerQ6K;EDO;702-984
Assess
Crystal Structure of EGFR T790M/V948R in Complex with Covalent Pyrrolopyrimidine 19monomerN7B;SO4;701-982
Assess
Crystal structure of the inactive EGFR tyrosine kinase domain with erlotinibmonomerAQ4;703-984
Assess
EGFR kinase domain complexed with an imidazo[2,1-b]thiazole inhibitormonomerITI;703-983
Assess
A Structural Model for the Membrane-Bound Form of the Juxtamembrane Domain of the Epidermal Growth …monomer669-721
Assess
Spatial structure of EGFR transmembrane and juxtamembrane domains in DPC micellesmonomer642-690
Assess

3 Homology models

Oligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
monomer0.813qwq.1.A26-638
100.00
Assess
monomer0.717mn5.1.C29-623
56.15
Assess
monomer0.703gop.1.A676-1018
99.72
Assess

8 Homology models built on isoform sequence

IsoformOligo-stateLigandsQMEANDisCoTemplateRangeSeq id (%)
Isoform 2monomer0.833qwq.1.A26-404
99.75
Assess
Isoform 2monomer0.815wb7.2.A26-404
99.74
Assess
Isoform 3monomer0.833qwq.1.A26-636
98.74
Assess
Isoform 3monomer0.781ivo.1.B27-536
99.83
Assess
Isoform 3monomer0.516vwg.1.A354-673
26.15
Assess
Isoform 3monomer0.505u8q.1.A354-673
25.00
Assess
Isoform 4monomer0.833qwq.1.A26-627
100.00
Assess
Isoform 4monomer0.781ivo.1.B27-536
100.00
Assess

Alignments